In vitro exploration of the therapeutic potential of mesenchymal stem cell conditioned medium in endometriosis treatment by targeting apoptosis and cellular migration

通过靶向细胞凋亡和细胞迁移,体外探索间充质干细胞条件培养基在子宫内膜异位症治疗中的治疗潜力

阅读:1

Abstract

BACKGROUND: Endometriosis, a common gynecological disorder involving ectopic endometrial tissue, leads to infertility and chronic pain. Dysregulated apoptosis and abnormal cell migration are key pathological features. Given current treatment limitations, novel strategies like mesenchymal stem cells (MSC) derived conditioned media (CM) are explored due to their rich secretome. OBJECTIVE: To investigate the effects of CM from healthy menstrual blood-derived MSCs (MenSCs-CM) and human adipose tissue-derived MSCs (ADSCs-CM) on apoptosis and migration in endometriotic MenSCs. MATERIALS AND METHODS: This in vitro study involved the isolation of endometriotic MenSCs from infertile women (25-35 yr) via menstrual blood. Mononuclear cells were cultured to passage 3, and characterized using flow cytometry (CD29, CD44, CD73, CD105 positive; CD34, CD38, CD45 negative). CM was prepared separately from healthy donor MenSCs and ADSCs. Endometriotic MenSCs were treated with healthy MenSCs-CM and ADSCs-CM independently. Cell migration (scratch assay), apoptosis (Annexin V), and Bax mRNA levels and Bax/Bcl-2 ratio (real-time polymerase chain reaction) were evaluated. RESULTS: Both ADSCs-CM and MenSCs-CM significantly increased during early and late apoptosis in endometriotic MenSCs (p  <  0.001). Scratch assays showed significantly decreased MenSCs migration at 24, 48, and 72 hr (p  < 0.001, p = 0.003, p  <  0.001, respectively). Gene expression revealed significant increases in Bax mRNA (p = 0.013) and the Bax/Bcl-2 ratio (p = 0.044). CONCLUSION: CM from ADSCs and MenSCs of healthy women enhances apoptosis and inhibits endometriotic MenSCs migration in vitro, suggesting potential therapeutic strategies for endometriosis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。